# Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII

> **NCT01918150** · PHASE4 · UNKNOWN · sponsor: **Hexacath, France** · enrollment: 1350 (estimated)

## Conditions studied

- Silent Myocardial Infarction
- Stable Angina
- Acute Coronary Syndrome

## Interventions

- **DEVICE:** Titan 2 stents
- **DEVICE:** Cobalt-Chromium Bare Metal Stents

## Key facts

- **NCT ID:** NCT01918150
- **Lead sponsor:** Hexacath, France
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 1350 (ESTIMATED)
- **Last updated:** 2014-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01918150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01918150, "Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01918150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*